Sequel ’s twiist™ Automated Insulin Delivery System Receives FDA 510(k) Clearance

MANCHESTER, N.H., March 18, 2024 (GLOBE NEWSWIRE) -- Sequel Med Tech, LLC, a company developing state-of-the-art insulin delivery technologies, today announced its partner, DEKA Research & Development Corp., has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the…#manchester #nh #sequelmedtech #llc #fda #aid #cgm #alanlotvin #tidepoolloop #tidepool
Source: Reuters: Health - Category: Consumer Health News Source Type: news